Chinese defendants seek to regain initiative in US court fights with increased IPR filings

Beijing-based medical device manufacturer BMC Medical this week touted a recent inter partes review (IPR) decision knocking out a patent that competitor ResMed has used to sue the Chinese company in the US. The two companies make masks and…

Get unlimited access to all IAM content